- Report
- October 2024
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- December 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- November 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- September 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- January 2025
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 141 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- August 2024
- 142 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- April 2024
- 137 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- March 2025
- 191 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 89 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 199 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 173 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 193 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 168 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 193 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 194 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 173 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more